Levonorgestrel Intrauterine Device Placement in a Premenopausal Breast Cancer Patient with a Bicornuate Uterus.
Young women with breast cancer face contraceptive challenges. Data are limited and conflicting on the use of the levonorgestrel intrauterine device (LNG-IUD) in this patient population. A 32-year-old nulligravid woman with a history of breast cancer on tamoxifen presented with new-onset vaginal bleeding. Further workup revealed a previously undiagnosed bicornuate uterus. She underwent hysteroscopy, dilation and curettage, and LNG-IUD placement in each uterine horn. Postoperative follow-up confirmed retention and proper placement of both IUDs. Pathology from the dilation and curettage was benign, and the abnormal uterine bleeding abated. LNG-IUD placement in a young patient with a personal history of breast cancer on tamoxifen and a bicornuate uterus is a safe and feasible alternative for contraception.
Department of Obstetrics and Gynecology, Carolinas Medical Center, Charlotte, North Carolina.
Ashley M
AM
Eskew
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Carolinas Medical Center, Charlotte, North Carolina. Electronic address: erin.crane@carolinashealthcare.org.
Erin K
EK
Crane
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000627:therapeutic use*; D013629:Tamoxifen / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014564:Urogenital Abnormalities; D014592:Uterine Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy; D014599:Uterus / Q000002:abnormalities* / Q000187:drug effects
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D016912:Levonorgestrel
Abnormal uterine bleeding; Bicornuate uterus; Breast Cancer; Fertility; Levonorgestrel-IUD